Benitec Biopharma Inc.
Financial highlights
| Metric | FY June 30, 2025 | FY June 30, 2024 | FY June 30, 2023 | FY June 30, 2022 | FY June 30, 2021 |
|---|---|---|---|---|---|
| Revenue | — | $0 | $75,000 | $73,000 | $59,000 |
| Operating income | -$41.8M | -$22.5M | -$19.1M | -$17.9M | -$13.6M |
| Operating expenses | $41.8M | $22.5M | $19.2M | $17.9M | $13.7M |
| Cash from operations | -$23.6M | -$19.4M | -$18.0M | -$15.9M | -$12.8M |
| Capital expenditure | $18,000 | $179,000 | $1,000 | $13,000 | $221,000 |
| Free cash flow | -$23.6M | -$19.6M | -$18.0M | -$15.9M | -$13.1M |
| Total assets | $99.6M | $52.2M | $4.5M | $6.0M | $21.4M |
| Total liabilities | $2.3M | $5.0M | $4.3M | $3.1M | $1.4M |
Shares outstanding 34.4M · Free float 94.2%
Annual filing data through FY ended June 30, 2025; float as of June 27, 2026.